Foley & Lardner represented Processa Pharmaceuticals, while Sichenzia Ross Ference represented Spartan Capital Securities in the offering.Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), a diversified clinical-stage company developing…
Processa Pharmaceuticals’ $6.25 Million Common Stock Offering

























